Astrazeneca
-
{
- All
- News
- Videos
- Web Stories
-
AstraZeneca's Experimental Stomach Cancer Drug Doubles Survival In Trial
AstraZeneca's experimental antibody-drug conjugate sonesitatug vedotin has doubled overall survival in a late-stage trial for advanced stomach cancer patients, offering renewed hope for hard-to-treat gastric cancers across global populations.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech
AstraZeneca would receive exclusive rights to develop and commercialise gene-editing therapies known as Crispr.
-
AstraZeneca Weighs Direct-To-Patient Drug Sales In US
Earlier this month, fellow European drugmaker Roche Holding AG said it was looking into direct sales to bypass players like pharmacy benefit managers.
-
Stocks To Watch Today: HCLTech, Rallis India, Tejas Networks, Brigade Enterprises, Deepak Fertilizer
Tata Tech, Sun Pharma and Oberoi Realty are also some of the other stocks to watch.
-
AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
The receipt of this permission paves way for the marketing of Durvalumab Solution.
-
AstraZeneca Sets Up Rs 166 Crore Global Hub To Boost AI Driven Healthcare
AstraZeneca sets up Rs 166 cr Global Hub to boost AI driven healthcare
-
AstraZeneca Inks China AI Research Deal For Chronic Diseases
British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
"Landmark Moment": UK Approves New Breast Cancer Drug
A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.
-
AstraZeneca Pharma Gets CDSCO Nod To Import New Drug For Hyperkalaemia Treatment
The permission paves way for the launch of sodium zirconium cyclosilicate powder for oral suspension 5 g and 10 g (Lokelma) in India.
-
AstraZeneca Pharma India Gets CDSCO Approval To Sell Cancer Treatment Drug
The approval from CDSCO is for import, sale and distribution of Durvalumab solution.
-
AstraZeneca Pharma India Gets Warning Letter From NSE
The warning letter was issued to AstraZeneca Pharma India for not complying with a regulatory norm that mandates the attendance of at least two independent directors in audit committee meeting.
-
AstraZeneca Pharma India Gets Warning Letter From NSE
The warning letter was issued to AstraZeneca Pharma India for not complying with a regulatory norm that mandates the attendance of at least two independent directors in audit committee meeting.
-
AstraZeneca's Experimental Stomach Cancer Drug Doubles Survival In Trial
AstraZeneca's experimental antibody-drug conjugate sonesitatug vedotin has doubled overall survival in a late-stage trial for advanced stomach cancer patients, offering renewed hope for hard-to-treat gastric cancers across global populations.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
AstraZeneca To Develop Gene-Editing Therapy Using Nobel Prize-Winning Tech
AstraZeneca would receive exclusive rights to develop and commercialise gene-editing therapies known as Crispr.
-
AstraZeneca Weighs Direct-To-Patient Drug Sales In US
Earlier this month, fellow European drugmaker Roche Holding AG said it was looking into direct sales to bypass players like pharmacy benefit managers.
-
Stocks To Watch Today: HCLTech, Rallis India, Tejas Networks, Brigade Enterprises, Deepak Fertilizer
Tata Tech, Sun Pharma and Oberoi Realty are also some of the other stocks to watch.
-
AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
The receipt of this permission paves way for the marketing of Durvalumab Solution.
-
AstraZeneca Sets Up Rs 166 Crore Global Hub To Boost AI Driven Healthcare
AstraZeneca sets up Rs 166 cr Global Hub to boost AI driven healthcare
-
AstraZeneca Inks China AI Research Deal For Chronic Diseases
British drugmaker AstraZeneca unveiled on Friday an AI-assisted research partnership with Chinese counterpart CSPC Pharmaceuticals worth up to $5.3 billion to tackle chronic diseases.
-
AstraZeneca Moves Some Production To US Amid Tariff Threat
British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.
-
"Landmark Moment": UK Approves New Breast Cancer Drug
A new drug that helps slow the spread of an incurable type of breast cancer has been approved for use in Britain's state-run National Health Service, officials said on Friday.
-
AstraZeneca Pharma Gets CDSCO Nod To Import New Drug For Hyperkalaemia Treatment
The permission paves way for the launch of sodium zirconium cyclosilicate powder for oral suspension 5 g and 10 g (Lokelma) in India.
-
AstraZeneca Pharma India Gets CDSCO Approval To Sell Cancer Treatment Drug
The approval from CDSCO is for import, sale and distribution of Durvalumab solution.
-
AstraZeneca Pharma India Gets Warning Letter From NSE
The warning letter was issued to AstraZeneca Pharma India for not complying with a regulatory norm that mandates the attendance of at least two independent directors in audit committee meeting.
-
AstraZeneca Pharma India Gets Warning Letter From NSE
The warning letter was issued to AstraZeneca Pharma India for not complying with a regulatory norm that mandates the attendance of at least two independent directors in audit committee meeting.
